EntreMed, Inc.

EntreMed, Inc.

EntreMed, Inc. was founded in 1991 and is headquartered in Rockville, Maryland. EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells and the blood vessels that nourish them. The Company focused on developing drugs that are safe and convenient, and provide the potential for improved patient outcomes. The Company has four compounds in clinical development with a pipeline of orally-active, multi-mechanism drugs for the treatment of cancer including; MKC-1, a cell cycle inhibitor, Panzem (2-methoxyestradiol or 2ME2), and ENMD-1198, an antimitotic agent. EntreMed also has active investigational new drug (IND) for its Aurora A/angiogenesis kinase inhibitor, ENMD-2076, and Panzem for rheumatoid arthritis.

Contact Details

Office Address

EntreMed, Inc.
9640 Medical Center Drive
Rockville, MD, USA 20850
Phone: (240) 864-2600
Fax: (240) 864-2601

Executives

Exec. Chairman and Member of Exec. Committee

Mr. Michael Tarnow J.D.

Principal Accounting Officer and Controller

Ms. Kathy R. Wehmeir-Davis

Business Reviews for EntreMed, Inc.

Related Companies